Abstract
Purpose
Multidisciplinary team (MDT) conferences are currently the standard of care in cancer patients’ management. Despite evidence supporting benefits to the majority of malignancies, a paucity of data exists examining the impact in urinary and male genital cancers. This study aims to evaluate the impact of MDT conferences in urologic cancer practice.
Methods
Clinical plans discussed in urologic MDT conferences in Centro Hospitalar Universitário de Lisboa Central between January 2019 and December 2019 were retrospectively analysed. Clinical plans were categorized as accepted, changed, rejected (cases that had to be re-presented to the MDT because of insufficient staging or administrative issues) or no plan. MDT conferences’ impact was assessed according to type of consultation, referral medical specialty and primary tumour type.
Results
710 clinical plans were discussed at the MDT conferences. 61.8% were accepted, 10.6% were changed, 16.5% were rejected and 11.1% of cases referred to MDT discussion had no defined clinical plan. First consultations had a higher rate of accepted clinical plans (63.4%) versus subsequent consultations (56.4%). Referrals by the urology specialty had the highest rate of acceptances (64.3%). On the stratification by primary tumour site, testicular cancer had the highest acceptance rate (70.3%), whereas bladder cancer had the lowest (47.8%).
Conclusions
MDT conferences had an important impact in the management of 38.2% of cases. Therefore, all patients with urologic malignancies should be referred to MDT review to ensure optimal clinical care.
Similar content being viewed by others
References
Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C (2017) Global burden of urologic cancers, 1990–2013. Eur Urol 71(3):437–446
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics. CA Cancer J Clin 70(1):7–30
Iyer NG, Chua MLK (2019) Multidisciplinary team meetings—challenges of implementation science. Nat Rev Clin Oncol 16(4):205–206
Sevdalis N, Green JSA (2014) Expanding the evidence for multidisciplinary team cancer care. Nat Rev Urol 11(12):668–669
Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P et al (2016) The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat Rev 42:56–72
Acher PL, Young AJ, Etherington-Foy R, McCahy PJ, Deane AM (2005) Improving outcomes in urological cancers: the impact of “multidisciplinary team meetings”. Int J Surg 3(2):121–123
Kurpad R, Kim W, Rathmell WK, Godley P, Whang Y, Fielding J et al (2011) A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions? Urol Oncol Semin Orig Investig 29(4):378–382
Rao K, Manya K, Azad A, Lawrentschuk N, Bolton D, Davis ID et al (2014) Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre—impact on clinical decision-making and implications for patient inclusion. BJU Int 114(Supplement 1):50–54
El Khoury R, Chahrouri M, Hachem C, Abi Zeid J, El Alam P, Abdessater M (2016) Evaluation of multidisciplinary team meetings in uro-oncology. Leban Med J 64(2):84–90
EAU (2020) EAU guidelines. EAU Guidelines Office, Arnhem
Funding
No financial support was provided.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Ethical approval
The study was conducted according to the ethical principles of the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gil, M., Guerra, J., Andrade, V. et al. The impact of multidisciplinary team conferences in urologic cancer in a tertiary hospital. Int Urol Nephrol 53, 41–47 (2021). https://doi.org/10.1007/s11255-020-02608-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-020-02608-6